PA
MLNT

PSI Advisors’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

PSI Advisors’s Portfolio MLNT Stock Details MLNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-564
Closed – – 690
2019
Q4 		$0 Buy
+564
New +$1.37K ﹤0.01% 692

PSI Advisors's MLNT Position: Q1 2020 in Review

PSI Advisors sold out of Melinta Therapeutics, Inc. Common Stock (MLNT) in Q1 2020, closing a stake of 564 shares.

PSI Advisors first reported a position in MLNT in Q4 2019 and held it in 1 quarter. The position peaked at $0 in Q4 2019. 2 funds tracked by Wall St. Rank hold MLNT as of Q1 2020.

  • PSI Advisors reported no remaining Melinta Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • PSI Advisors sold 564 Melinta Therapeutics, Inc. Common Stock shares in Q1 2020.
  • PSI Advisors first reported a position in Melinta Therapeutics, Inc. Common Stock in Q4 2019 and held it in 1 quarter.
  • PSI Advisors's Melinta Therapeutics, Inc. Common Stock position peaked at $0 in Q4 2019.
  • 2 funds tracked by Wall St. Rank held Melinta Therapeutics, Inc. Common Stock as of Q1 2020.

Based on PSI Advisors's 13F filing for Q1 2020, filed 15 May 2020.